Friday, November 13, 2026

Markets & Investment

4 articles

Pershing Square Backs Microsoft as Oracle Borrows Billions for Data Centers in Global AI Infrastructure Race

Pershing Square Backs Microsoft as Oracle Borrows Billions for Data Centers in Global AI Infrastructure Race

Bill Ackman's Pershing Square has taken a new stake in Microsoft while Oracle has borrowed against its balance sheet to fund data center expansion. Both moves signal institutional accumulation of AI infrastructure assets before public markets fully price the theme. The pattern echoes prior capital cycles — cloud in 2015, mobile networks in 2010 — when early movers locked in positions ahead of broader recognition.

LM Salvado•
Global Capital Exodus From Life Science Tech Signals AI Investment Realignment

Global Capital Exodus From Life Science Tech Signals AI Investment Realignment

10x Genomics' accelerating financial deterioration is exposing a fault line running through life science technology markets worldwide, as institutional investors pivot decisively toward core AI infrastructure. The pattern — visible from Silicon Valley to Singapore — suggests a structural repricing of companies that use AI tools versus those that build AI's foundational architecture. For the genomics sector globally, the reckoning has only begun.

ViaNews Editorial Team•
Dentsu's Japan Dependency: A Structural Risk Lesson for Global Holding Company Investors

Dentsu's Japan Dependency: A Structural Risk Lesson for Global Holding Company Investors

Dentsu Group, one of the world's largest advertising conglomerates, carries a hidden structural vulnerability: its Japanese operating arm contributes more than half of group profits despite generating only 40% of revenues. As global agency networks face mounting pressure from digital disruption and economic fragmentation, this concentration risk offers a cautionary case study for institutional investors evaluating diversified media and marketing groups worldwide.

ViaNews Editorial Team•
Vietnam's EV Ride-Hailing Ultimatum Triggers Southeast Asia's Next Infrastructure Gold Rush

Vietnam's EV Ride-Hailing Ultimatum Triggers Southeast Asia's Next Infrastructure Gold Rush

Ho Chi Minh City's mandate to fully electrify its ride-hailing fleet by 2030 is sending shockwaves through Southeast Asian capital markets, forcing platforms like Grab and Gojek to accelerate fleet transitions while unlocking a multibillion-dollar race for charging and battery-swap infrastructure. The policy mirrors aggressive EV mandates seen in Europe and China, but plays out against the distinctive economics of the gig-driver model dominant across the Global South. Investors and development f

ViaNews Editorial Team•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com